SCHEMBL4470548

SCHEMBL4470548

O=C(CCN1CCCC1)Nc1cccc(C(=O)NCCN2CCC(OC(=O)N(c3ccccc3-c3ccccc3)N(C(=O)O)c3ccccc3-c3ccccc3)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ATR Q13535 2/20 0.44
EPHX2 P34913 3/20 0.44
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 1/20 0.41
TRPV1 Q8NER1 4/20 0.41
SMYD2 Q9NRG4 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADRB2 P07550 1/20 0.40
CHRM3 P20309 1/20 0.40
MEN1 O00255 1/20 0.40
IKBKB O14920 1/20 0.40
CHUK O15111 1/20 0.40
HTR7 P34969 2/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4486948 0.94 EPHX2 (0.44) ATREPHX2KMT2AALDH1A1POLB
SCHEMBL4487942 0.93 NPSR1 (0.49) ATREPHX2KMT2AALDH1A1POLB
SCHEMBL4480181 0.92 CARM1 (0.47) EPHX2CHRM3HTR7HTR1A
SCHEMBL4472540 0.92 EPHX2 (0.43) ATREPHX2ADRB2CHRM3HTR7
SCHEMBL4490817 0.91 CHRM3 (0.41) EPHX2ADRB2CHRM3HTR7HTR1A
SCHEMBL4470442 0.90 CARM1 (0.46) EPHX2CHRM3HTR7HTR1A
SCHEMBL4494143 0.90 EPHX2 (0.44) ATREPHX2ADRB2CHRM3HTR7
SCHEMBL4480375 0.90 EPHX2 (0.44) ATREPHX2CHRM3HTR7HTR1A
SCHEMBL4480537 0.89 EPHX2 (0.43) ATREPHX2KMT2AALDH1A1LMNA
SCHEMBL4482918 0.89 EPHX2 (0.43) EPHX2ADRB2CHRM3HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632847-B2 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(3-[3-(4-hydroxybenzylamino)propionylamino]benzoylamino)ethyl)piperidin-4-yl ester THERAVANCE, INC. (US) 2009-12-15 US disclosed